Stay updated on Pembrolizumab vs Placebo in HCC Adjuvant Therapy Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in HCC Adjuvant Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Placebo in HCC Adjuvant Therapy Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-10T15:25:05.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The Study Results section now shows 'Results Submitted' instead of 'No Results Posted'. This indicates that results have been submitted for the trial.
    Difference
    0.0%
    Check dated 2026-03-03T10:57:10.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page revision is updated from v3.4.1 to v3.4.2, with no changes to core study details or patient information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-17T02:28:46.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Added detailed patient-reported outcome (PRO) endpoints, including EORTC QLQ-C30 and QLQ-HCC18 measures and time-to-deterioration metrics for quality of life and symptoms. Also removed older PRO descriptions and certain administrative notices from the page.
    Difference
    0.7%
    Check dated 2026-02-09T21:44:10.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    A new site-wide notice banner informs users about potential delays and current operating status due to a lapse in government funding, with links to cc.nih.gov and opm.gov. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-02T18:11:20.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    Added a Show glossary option, adjusted capitalization for labels (Last Update Submitted that Met QC Criteria; No FEAR Act Data), and updated the revision to v3.4.0.
    Difference
    0.1%
    Check dated 2026-01-26T16:25:27.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Placebo in HCC Adjuvant Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in HCC Adjuvant Therapy Clinical Trial page.